Ari Rotenberg’s clinical internship with the BC Cancer Agency

Glioblastoma is an aggressive and universally fatal form of brain cancer. Without a cure, doctors, patients, and caregivers must share sensitive conversations to determine what successful treatment entails. Under the guidance of Dr. Rebecca Harrison, neuro-oncologist at the BC Cancer Agency (BCCA) and Clinical Assistant Professor at UBC, Ari is developing a survey to identify what gaps remain in stakeholders’ conceptions of treatment considerations despite in-clinic conversations. Ari also aims to understand how these concepts converge and diverge across the course of treatment. The results of this study will benefit doctors, patients, and caregivers alike by highlighting obstacles in clinical communications and suggesting practices to improve coherent and collaborative care.

Ari is a MSc student in the Experimental Program at UBC under the supervision of Dr. Judy Illes. To learn more about Ari’s work with Neuroethics Canada, head over to People and look for Ari under “Illes Group.”